Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

13.06
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
10.07
Today|||52-Week Range
14.87
+22.06%
Year-to-Date
Theravance Shares Rise on Approval of Glaxo's COPD Therapy
Nov 17 / Zacks.com - Paid Partner Content
Glaxo's Triple Therapy COPD Inhaler Gets Marketing Nod in EU
Nov 17 / Zacks.com - Paid Partner Content